Find our Science Published in
"A passionate and deeply knowledgeable team seeking to create meaningful societal impact by harnessing the power of exponential technologies."
CurrentPress
Solarea Bio to Showcase Innovations at 2025 Future Food-Tech Summit
Solarea Bio, a clinical-stage biotechnology company unlocking the power of the edible plant microbiota to improve human health, is showcasing its innovative natural solutions for some inflammatory-related health conditions such as postmenopausal bone loss and rheumatoid arthritis at the Future Food-Tech Summit on March 13-14 in San Francisco.
Solarea Bio Aims to Transform Dietary Management of Age-Related Health Conditions with New Class of Medical Foods
Solarea Bio enters 2025 following an impactful year of pioneering natural solutions for some of the most prevalent age-related health conditions, including postmenopausal bone loss and chronic autoimmune diseases.
Journa Unveils Bondia™: A Daily Synbiotic Medical Food for the Dietary Management of Bone Loss Associated with Menopause, Weight, and Aging
Journa is excited to announce the introduction of Bondia™, scientifically formulated daily synbiotic medical food designed to support bone health and slow bone loss associated with menopause, weight and aging.
Ilissa Larimore Appointed Chief Commercial Officer at Solarea Bio
Solarea announces the appointment of Ilissa Larimore as Chief Commercial Officer (CCO). Ilissa joins Solarea Bio with over 20 years of experience in consumer health, personalized wellness and practitioner engagement to help individuals achieve optimal health.